tiprankstipranks
Trending News
More News >
Stevanato Group (STVN)
NYSE:STVN
US Market
Advertisement

Stevanato Group (STVN) Earnings Dates, Call Summary & Reports

Compare
132 Followers

Earnings Data

Report Date
Mar 05, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
0.2
Last Year’s EPS
0.22
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 06, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a positive overall sentiment, highlighting strong revenue growth and margin expansion driven by high-value solutions. However, challenges persist in the Engineering segment and from foreign currency impacts. The company's strategic investments and strong ESG performance are viewed favorably.
Company Guidance
During the Stevanato Group's third-quarter 2025 earnings call, the company highlighted several key metrics and updates. The group reported a 9% year-over-year revenue increase to $303.2 million, with the Biologics Drug Solutions (BDS) segment growing by 14%, driven by a strong demand for high-value solutions like Nexa syringes and EZ-fill vials. These high-value solutions experienced a remarkable 47% growth and accounted for 49% of the total revenue. Despite facing foreign currency and tariff headwinds, the company maintained its guidance, expecting fiscal 2025 revenue between $1.16 billion and $1.19 billion, adjusted EBITDA of $288.5 million to $301.8 million, and adjusted diluted EPS of $0.50 to $0.54. The Engineering segment faced challenges, with a 19% revenue decline, but the company is optimistic about future opportunities and operational improvements. Furthermore, Stevanato's ongoing capacity expansion, especially in the Fishers and Latina facilities, is expected to support future growth and meet increasing demand for drug containment products.
Record Revenue Growth
Third-quarter revenue increased by 9% year-over-year, driven by a 14% increase in the BDS segment, primarily fueled by demand in the core drug containment business.
Strong Performance in High-Value Solutions
Revenue from high-value solutions grew 47%, representing 49% of total company revenue, driven by demand for Nexa syringes and EZ-fill vials.
Margin Expansion
Consolidated gross profit margin increased by 240 basis points to 29.2%, and adjusted EBITDA margin improved by 280 basis points to 25.7%.
Successful Capital Investments
Notable progress in capacity expansion at Fishers and Latina sites, supporting future growth.
EcoVadis Silver Medal
Awarded the EcoVadis silver medal, placing the company in the top 15% of companies assessed globally, recognizing strong performance in ESG practices.

Stevanato Group (STVN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

STVN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 05, 2026
2025 (Q4)
0.20 / -
0.22
Nov 06, 2025
2025 (Q3)
0.15 / 0.16
0.13916.67% (+0.02)
Aug 05, 2025
2025 (Q2)
0.13 / 0.13
0.10422.22% (+0.02)
May 08, 2025
2025 (Q1)
0.10 / 0.12
0.09325.00% (+0.02)
Mar 06, 2025
2024 (Q4)
0.21 / 0.22
0.2085.56% (+0.01)
Nov 05, 2024
2024 (Q3)
0.15 / 0.14
0.174-20.00% (-0.03)
Aug 06, 2024
2024 (Q2)
0.11 / 0.10
0.162-35.71% (-0.06)
May 09, 2024
2024 (Q1)
0.13 / 0.09
0.127-27.27% (-0.03)
Mar 07, 2024
2023 (Q4)
0.22 / 0.21
0.22-5.26% (-0.01)
Oct 31, 2023
2023 (Q3)
0.18 / 0.17
0.1627.14% (+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

STVN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2025
$25.00$24.41-2.36%
Aug 05, 2025
$25.58$23.09-9.73%
May 08, 2025
$21.74$22.42+3.13%
Mar 06, 2025
$19.01$20.64+8.57%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Stevanato Group (STVN) report earnings?
Stevanato Group (STVN) is schdueled to report earning on Mar 05, 2026, Before Open (Confirmed).
    What is Stevanato Group (STVN) earnings time?
    Stevanato Group (STVN) earnings time is at Mar 05, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is STVN EPS forecast?
          STVN EPS forecast for the fiscal quarter 2025 (Q4) is 0.2.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis